The relation between c-myc expression and interferon sensitivity in uveal melanoma
Open Access
- 1 December 2004
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 88 (12) , 1563-1567
Abstract
Background/aim: Interferons (IFN) are currently being used to treat melanoma, including some patients with uveal melanoma. IFN is thought to inhibit tumour growth through downregulation of the c-myc oncogene; the overexpression of which has been shown to be associated with resistance in cell lines. The aim of this study was to investigate the relation between c-myc gene expression and IFN sensitivity in a series of uveal melanomas in a short term chemosensitivity assay. Methods: Tumours from 45 patients with uveal melanoma who had undergone enucleation were studied. The ATP chemosensitivity assay was used to study sensitivity to IFN-α-2b in freshly isolated cells from each tumour. Flow cytometry was used to assess c-myc expression in formalin fixed material from the primary specimens. Results: There was a wide range of IFN sensitivity between the specimens whereas c-myc expression was universal and present in 80% of the tumour cells in 80% of the specimens. Higher c-myc expression was associated with IFN-α resistance as measured by the maximum percentage of inhibition (p = 0.05) and there was a trend with the IFN sensitivity index (p = 0.07). Conclusions: These results demonstrate that tumours with high c-myc expression are also associated with IFN resistance. Future research is required to explore the potential of c-myc gene manipulation combined with IFN therapy.Keywords
This publication has 41 references indexed in Scilit:
- Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanomaCancer, 2002
- HLA expression in uveal melanoma: there is no rule without some exceptionHuman Immunology, 2002
- Tumor doubling times in metastatic malignant melanoma of the uvea Tumor progression before and after treatmentOphthalmology, 2000
- Uveal melanomaMelanoma Research, 1999
- Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell lineOncogene, 1998
- Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanomaBritish Journal of Surgery, 1998
- HLA expression in a primary uveal melanoma, its cell line, and four of its metastasesBritish Journal of Ophthalmology, 1997
- C-myc oncogene expression in human melanoma and its relationship with tumour antigenicityEuropean Journal of Surgical Oncology, 1996
- Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.British Journal of Ophthalmology, 1995
- Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary culturesAnti-Cancer Drugs, 1995